Brainstorm Cell Therapeutics Inc.
BCLI- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001137883
No open-market purchases or sales by Brainstorm Cell Therapeutics Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Brainstorm Cell Therapeutics Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 52 | 1 | 42 | −9 |
| Shares | 5.13M | 17.0K | 4.40M | −714.9K (−14.0%) |
| Value | $16.9M | $56.0K | $17.6M | +$715.0K (+4.2%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| S.C. Financial Services, Inc. | 15,285 | $52.0K | 0.06% |
| Geneos Wealth Management Inc. | 10,100 | $40.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 3,442 | $14.0K | 0.00% |
| Cypress Capital Management LLC (WY) | 1,500 | $6.00K | 0.01% |
| Aquatic Capital Management LLC | 800 | $3.00K | 0.01% |
| CoreCap Advisors, LLC | 133 | $1.00K | 0.00% |
Sold out (15)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Gsa Capital Partners LLP | 172,056 | $568.0K |
| Ergoteles LLC | 122,667 | $405.0K |
| Pura Vida Investments, LLC | 106,834 | $353.0K |
| HRT Financial LP | 81,489 | $268.0K |
| Susquehanna International Group, LLP | 39,031 | $129.0K |
| Acadian Asset Management LLC | 35,893 | $118.0K |
| Goldman Sachs Group Inc | 17,600 | $58.0K |
| Citadel Advisors LLC | 16,480 | $54.0K |
| Two Sigma Investments, LP | 15,900 | $52.0K |
| Walleye Capital LLC | 10,639 | $35.0K |
| Occudo Quantitative Strategies LP | 10,168 | $34.0K |
| Barclays PLC | 4,267 | $14.0K |
| Deutsche Bank AG | 2,100 | $7.00K |
| Brewin Dolphin Ltd | 700 | $2.31K |
| FMR LLC | 666 | $2.00K |
Not filed for Q4 2021 yet (1)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| HighPoint Advisor Group LLC | 17,033 | $56.0K |